Trial Profile
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Linaprazan-glurate (Primary) ; Omeprazole
- Indications Oesophagitis
- Focus Adverse reactions; First in man
- Sponsors Cinclus Pharma
- 24 Oct 2018 Results of the Single Ascending Dose (SAD) cohort, presented at the 26th United European Gastroenterology Week
- 11 Apr 2017 New trial record